Gini Fleming to Neoplasms, Cystic, Mucinous, and Serous
This is a "connection" page, showing publications Gini Fleming has written about Neoplasms, Cystic, Mucinous, and Serous.
Connection Strength
0.196
-
Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer - an ancillary data analysis of the VELIA trial. Gynecol Oncol. 2022 02; 164(2):278-287.
Score: 0.196